Sign inGet started

Baluch Khoso

Insider CIK 1686223 · CRMD Chief Executive Officer, Director · PCSA Director · LGVN Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PCSA Processa Pharmaceuticals, A Award deriv2026-07-262026-07-2833,500— $038,749SEC↗
PCSA Processa Pharmaceuticals, A Award deriv2026-07-262026-07-2833,500— $038,749SEC↗
PCSA Processa Pharmaceuticals, M Exercise deriv2026-06-262026-06-30203— $05,249SEC↗
PCSA Processa Pharmaceuticals, M Exercise2026-06-262026-06-30203— $02,528SEC↗
PCSA Processa Pharmaceuticals, P Buy2026-03-312026-04-012,269$2.54 $5.8K2,325SEC↗
PCSA Processa Pharmaceuticals, A Award deriv2025-10-012025-10-03300,000— $0300,000SEC↗
PCSA Processa Pharmaceuticals, A Award deriv2025-10-012025-10-03100,000— $0100,000SEC↗
LGVN Longeveron Inc. P Buy deriv2025-08-112025-08-1329,415— $029,415SEC↗
LGVN Longeveron Inc. P Buy2025-08-112025-08-1311,766— $052,516SEC↗
PCSA Processa Pharmaceuticals, A Award deriv2025-07-242025-07-28175,299— $0206,505SEC↗
LGVN Longeveron Inc. A Award2025-07-152025-07-1717,000— $040,750SEC↗
LGVN Longeveron Inc. S Sale2024-12-022024-12-041,250$2.07 $2.6K23,750SEC↗
PCSA Processa Pharmaceuticals, A Award deriv2024-09-032025-09-1831,206— $036,275SEC↗
PCSA Processa Pharmaceuticals, A Award deriv2024-09-032024-09-1831,206— $031,206SEC↗
LGVN Longeveron Inc. A Award2024-08-152024-08-1923,500— $038,375SEC↗
LGVN Longeveron Inc. F Tax w/h2024-06-092024-06-11125$1.06 $13314,875SEC↗
LGVN Longeveron Inc. P Buy2023-12-292024-01-028,322$1.43 $11.9K15,000SEC↗
LGVN Longeveron Inc. P Buy2023-12-282024-01-021,678$1.40 $2.3K6,678SEC↗
LGVN Longeveron Inc. A Award deriv2023-12-212023-12-2612,000— $012,000SEC↗
PCSA Processa Pharmaceuticals, A Award deriv2023-06-272023-07-24101,365— $0101,365SEC↗
PCSA Processa Pharmaceuticals, M Exercise deriv2023-06-272023-07-2415,455— $00SEC↗
PCSA Processa Pharmaceuticals, M Exercise2023-06-272023-07-2415,455— $027,955SEC↗
LGVN Longeveron Inc. A Award2023-06-092023-06-125,000— $05,000SEC↗
PCSA Processa Pharmaceuticals, A Award2023-02-092023-02-1012,500$0.80 $10.0K12,500SEC↗
PCSA Processa Pharmaceuticals, A Award deriv2022-07-122022-07-1419,091— $019,091SEC↗
CRMD CorMedix Inc. A Award deriv2021-01-112021-01-13320,000— $0320,000SEC↗
CRMD CorMedix Inc. P Buy2020-08-132020-08-174,830$4.14 $20.0K60,905SEC↗
CRMD CorMedix Inc. P Buy2020-03-182020-03-183,500$2.61 $9.1K56,075SEC↗
CRMD CorMedix Inc. A Award deriv2020-02-252020-02-27100,630$5.63 $566.5K100,630SEC↗
CRMD CorMedix Inc. A Award deriv2019-09-262019-09-30120,000— $0120,000SEC↗
CRMD CorMedix Inc. P Buy2019-03-262019-03-272,500$7.55 $18.9K52,575SEC↗
CRMD CorMedix Inc. A Award deriv2019-01-102019-01-11400,000— $0400,000SEC↗
CRMD CorMedix Inc. P Buy2018-11-272018-11-2721,500$1.21 $26.0K250,373SEC↗
CRMD CorMedix Inc. P Buy2018-11-262018-11-273,500$1.28 $4.5K228,873SEC↗
CRMD CorMedix Inc. A Award deriv2018-02-162018-02-20225,000— $0225,000SEC↗
CRMD CorMedix Inc. P Buy2017-12-122017-12-14104,166$0.48 $50.0K225,373SEC↗
CRMD CorMedix Inc. P Buy2017-08-182017-08-2236,207$0.42 $15.2K121,207SEC↗
CRMD CorMedix Inc. P Buy2017-05-172017-05-1975,000$0.48 $36.0K85,000SEC↗
CRMD CorMedix Inc. P Buy2016-12-092016-12-1310,000$1.77 $17.7K10,000SEC↗
CRMD CorMedix Inc. A Award deriv2016-10-032016-10-051,250,000— $01,250,000SEC↗
CRMD CorMedix Inc. A Award deriv2016-10-032016-10-05300,000— $0300,000SEC↗
CRMD CorMedix Inc. A Award deriv2016-10-032016-10-05300,000— $0300,000SEC↗
CRMD CorMedix Inc. A Award deriv2016-10-032016-10-111,250,000— $01,250,000SEC↗
CRMD CorMedix Inc. A Award deriv2016-10-032016-10-11300,000— $0300,000SEC↗
CRMD CorMedix Inc. A Award deriv2016-10-032016-10-11300,000— $0300,000SEC↗